Mitigating International Legal Risk: IP Due Diligence Considerations for Global Deals

November 9, 2020 5:00pm

Yu-Ming Dammann
Associate General Counsel
Gilead Sciences (Seattle, WA)

Janet Xiao
Partner
Morrison & Foerster LLP (San Francisco, CA)

  • Identifying due diligence landmines that U.S. practitioners should avoid when doing deals globally
  • Assessing how the new CFIUS regulations are increasing government scrutiny over foreign investment in U.S. biotech companies, and the impact this has on due diligence relating to deals with such companies
  • Evaluating foreign IP assets based upon the specific rules for their jurisdiction